SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a g…
Industry Peers
Medical Instruments & Supplies| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
Older | ||
Schott Pharma AG & CO KGaA (WBO:1SXP) (Q3 2026) Earnings Call Highlights: Strong Q3 Growth ... Schott Pharma AG & CO KGaA (WBO:1SXP) reports 8.3% constant-currency revenue growth in Q3, lifts full-year outlook, and secures a key take-or-pay glass syringe agreement. | ||
DDer Aktionär | ||
 SCHOTT Pharma AG & Co. KGaA Just Beat EPS By 7.5%: Here's What Analysts Think Will Happen Next Investors in SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) had a good week, as its shares rose 4.9% to close at €16.38... | ||
Schott Pharma AG & CO KGaA (WBO:1SXP) Q2 2026 Earnings Call Highlights: Resilient ... Despite headwinds in the DDS segment, Schott Pharma AG & CO KGaA (WBO:1SXP) maintains growth momentum and confirms full-year guidance. | ||
Is Now An Opportune Moment To Examine SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)? While SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) might not have the largest market cap around , it saw a significant... | ||
Schott Pharma AG & CO KGaA (SHTPY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ... Despite challenges, Schott Pharma AG & CO KGaA (SHTPY) reports robust financial performance with innovative product launches and strategic expansions. | ||
There's A Lot To Like About SCHOTT Pharma KGaA's (ETR:1SXP) Upcoming €0.18 Dividend SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) is about to trade ex-dividend in the next 3 days. Typically, the ex-dividend... | ||
SCHOTT Pharma KGaA's (ETR:1SXP) Shareholders Will Receive A Bigger Dividend Than Last Year SCHOTT Pharma AG & Co. KGaA's ( ETR:1SXP ) dividend will be increasing from last year's payment of the same period to... | ||
Earnings Update: SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Just Reported And Analysts Are Trimming Their Forecasts There's been a notable change in appetite for SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) shares in the week since its... | ||
Schott Pharma AG & CO KGaA (WBO:1SXP) Q4 2025 Earnings Call Highlights: Strong Revenue ... Schott Pharma AG & CO KGaA (WBO:1SXP) reports robust financial performance for fiscal year 2025, while navigating a challenging market environment with strategic expansions and innovations. | ||
A Look At The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Key Insights SCHOTT Pharma KGaA's estimated fair value is €21.38 based on 2 Stage Free Cash Flow to Equity Current... | ||